🇺🇸 FDA
Pipeline program

mifepristone

13-CH-0170

Phase 3 small_molecule terminated

Quick answer

mifepristone for Cushing's Disease is a Phase 3 program (small_molecule) at CORCEPT THERAPEUTICS INC with 2 ClinicalTrials.gov record(s).

Program details

Company
CORCEPT THERAPEUTICS INC
Indication
Cushing's Disease
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials